NCT02561234 2021-11-05A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid TumorsAeglea BiotherapeuticsPhase 1/2 Completed98 enrolled
NCT01021072 2021-02-16A First in Man Study of MABp1 in Patients With Advanced CancersJanssen Research & Development, LLCPhase 1 Completed52 enrolled